Company Filing History:
Years Active: 2023
Title: Innovations of Angela Hidalgo Gajardo
Introduction
Angela Hidalgo Gajardo is a prominent inventor based in Concepción, Chile. She has made significant contributions to the field of veterinary medicine through her innovative research and development of vaccines. Her work focuses on addressing critical health issues in animals, particularly through the use of recombinant technology.
Latest Patents
Angela Hidalgo Gajardo holds a patent for a recombinant vaccine against proliferative enteropathy in animals. This invention is based on a recombinant synthetic chimeric variant of membrane proteins and invasins of the bacteria responsible for the disease. The patent also includes synthetic nucleotide sequences encoding these protein variants, recombinant proteins, an expression cassette of the synthetic protein antigens, and a transformed cell. The method for producing these antigens demonstrates their antigenicity and protective potential against the pathogen.
Career Highlights
Angela is affiliated with the Universidad de Concepción, where she conducts her research and develops her inventions. Her work has garnered attention for its potential impact on animal health and welfare. With her innovative approach, she aims to improve the effectiveness of vaccines in combating diseases that affect livestock and other animals.
Collaborations
Angela has collaborated with notable colleagues, including Raquel Montesino Segui and Jorge Toledo Alonso. These partnerships have enhanced her research efforts and contributed to the advancement of veterinary medicine.
Conclusion
Angela Hidalgo Gajardo's contributions to the field of veterinary medicine through her innovative vaccine development highlight her role as a leading inventor. Her work not only addresses significant health challenges in animals but also showcases the potential of recombinant technology in creating effective solutions.